Falls Church: Innovation Health, a unique partnership between two industry leaders, Inova and Aetna, and Sanofi, a global healthcare leader, announced a new pilot program for people living with Type 2 diabetes. The pilot program will work to study the impact of novel digital health solutions from One Drop® and Gocap® to help patient outcomes and medication adherence.
“Creating unique relationships and implementing innovative care solutions is part of Innovation Health’s DNA,” said Innovation Health’s Chief Medical Officer and Chief Medical Informatics Officer, Dr. Sunil Budhrani. “As overall Type 2 diabetes diagnosis rates continue to rise, especially among children and teens, this pilot program will enable us to better understand, in adults 18 to 65 years old, how new technologies can help improve public health.”
The goal of the pilot program is for pharmaceutical companies, technology companies and plan providers to work more closely together to help improve patient outcomes. To achieve this, the pilot program will utilize two digital health technologies.
One Drop®, an evidence-based, clinically effective diabetes self-management platform, which includes a Bluetooth® enabled blood glucose monitor, ADA recognized diabetes coaching and education and an award-winning mobile app. The One Drop® platform measures, stores, analyzes and transmits participant’s blood glucose, medication, diet and physical activity directly to the cloud. Participants can communicate with their coaches anytime 24/7, via in-app chat. All data recorded in the app is available to coaches in real-time, allowing them to provide personalized guidance when participants need it most.
Common Sensing’s Gocap® is a low effort way to provide clinicians with real-life feedback on what people are doing with their insulin. The Gocap Clinical Dashboard highlights easy, high-value ways to connect with patients who are struggling with insulin use, and does so at the right time to adjust treatment strategies. A recent study involving Gocap and Continuous Glucose Monitoring showed that care providers gleaned actionable insights for almost every patient using insulin with Gocap. By providing direct data about insulin use, the Gocap closes the gap between patient experience and physician knowledge.
“As a leader in diabetes, our ambition is to empower people with diabetes to live the life they want,” said Vice President of Innovative Solutions, US DCV at Sanofi, Sebastien Coisne. “We believe that combining innovative medicines with connected devices and solutions leads to better patient outcomes and an improved patient experience. As innovative solutions come to market, we are very excited to work with Innovation Health on this pilot program and trust it will provide further insights to achieve that goal.”
The findings of the pilot will be analyzed to gain insights into potential best practices for industry arrangements and overall treatment of people living with diabetes. The pilot program will be facilitated by Innovation Health, Inova Health Systems and Healthagen, a division of Aetna.
Latest posts by supriya kashyap (see all)
- Natco’s partner Alvogen gets nod for influenza drug in US - November 6, 2017
- USFDA moves to more efficient global pharmaceutical manufacturing inspections - November 6, 2017
- Sanofi refines expectations on drop in sales at diabetes arm - November 6, 2017